Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Integrated Health Services/Coram merger terminated; Coram will pursue lawsuit against Caremark.

Executive Summary

IHS/CORAM MERGER CALLED OFF AFTER REJECTION OF AMENDED EXCHANGE OFFER by Coram Healthcare, which would have reduced the number of Integrated Health Services shares issued for each share of Coram stock from .21 to .15. Coram and IHS executed the amendment to the agreement on March 30. It was to become effective at the close of business on April 4, "unless either party gives the other prior notice of cancellation of the amendment," Coram said. Coram announced April 7 that it had received from IHS a notice of termination of the amendment and of the merger agreement itself. Coram said IHS will pay Coram $17.5 mil. plus expenses still to be determined.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS030154

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel